C.H. Robinson Worldwide, Inc. · CHRW · FY2024 Q3 · Calendar Q4 2024
C.H. Robinson: Strong execution, but Q4 freight risks remain
The current analysis supports a measured constructive view: execution, productivity, digital tools, and market-share initiatives are improving the operating profile, but the durability of those gains remains dependent on freight conditions and disciplined cost control.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about CHRW FY2024 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior analysis, the current quarter showed stronger enterprise execution and a larger contribution from Global Forwarding, while management added clearer caution that peaked ocean rates could create Q4 pressure. The operating-model, AI, and productivity themes remained consistent.
Guidance delta
Management guidance sentiment was maintained; the key change was greater emphasis on execution, productivity, and technology while acknowledging potential Q4 pressure from lower ocean rates.
Key takeaways
- Management described continued operating-model execution, pricing discipline, and productivity gains as central to margin expansion.
- Digital brokerage and generative-AI tools are being scaled across the order lifecycle, alongside investment in drop-trailer capabilities.
- The outlook is constructive on market-share opportunities, but softer ocean rates and an uncertain freight recovery remain material offsets.
Management priorities
- Scale the operating model and lean processes.
- Expand AI-enabled pricing, revenue management, and digital brokerage.
- Invest in technology and talent while pursuing disciplined pricing and market-share gains.
Follow CHRW with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 16, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Buy | Buy | Maintain | Oct 7, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 6, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 5, 2026 |
| Citigroup | Buy | Neutral | Upgrade | Sep 8, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Aug 11, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 31, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jul 30, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 28, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 14, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 14, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Jul 6, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Jul 2, 2026 |
| UBS | Buy | Buy | Maintain | Jun 1, 2026 |
| Jefferies | Buy | Hold | Upgrade | May 20, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 30, 2026 |
| B of A Securities | Buy | Buy | Maintain | Mar 27, 2026 |
| Freedom Broker | Hold | Hold | Maintain | Feb 2, 2026 |
| Benchmark | Buy | Buy | Maintain | Jan 30, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 30, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Oct 2, 2025 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jul 1, 2025 |
| TD Securities | Hold | Hold | Maintain | May 1, 2025 |
| Loop Capital | Buy | Buy | Maintain | Aug 18, 2023 |
| Credit Suisse | Underperform | Underperform | Maintain | Aug 16, 2023 |
| Keybanc | Overweight | Overweight | Maintain | Jan 11, 2023 |
| Cowen & Co. | Market Perform | Outperform | Downgrade | Jan 5, 2023 |
| Vertical Research | Sell | Hold | Downgrade | Aug 17, 2022 |
| Bank of America | Underperform | Neutral | Downgrade | Oct 30, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Aug 3, 2018 |
| BB&T Capital | Hold | Buy | Downgrade | Apr 27, 2016 |
| Buckingham Research | Buy | Buy | Maintain | Apr 21, 2016 |
| RBC Capital | Outperform | Sector Perform | Upgrade | Jan 7, 2016 |
| Cleveland Research | Neutral | Buy | Downgrade | Mar 11, 2015 |
| Nomura | Neutral | Neutral | Maintain | Dec 10, 2014 |
| Macquarie | Neutral | Neutral | Maintain | Oct 15, 2014 |
| Edward Jones | Hold | Sell | Upgrade | Jul 31, 2014 |
| FBR Capital | Market Perform | Underperform | Upgrade | Mar 31, 2014 |
| Wunderlich Securities | Hold | Hold | Maintain | Feb 6, 2014 |
| Wunderlich | Hold | Hold | Maintain | Feb 6, 2014 |
| Sterne Agee | Buy | Buy | Maintain | Oct 23, 2012 |
| Longbow Research | Neutral | Neutral | Maintain | Aug 9, 2012 |
| Avondale Partners | Market Perform | Outperform | Downgrade | Jul 25, 2012 |
| Oppenheimer | Perform | Perform | Maintain | May 11, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $143.82. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Raymond James | David Hicks | $170 | $141.38 | +18.2% | Oct 15, 2026 |
| Deutsche Bank | Analyst unavailable | $153 | $142.31 | +6.4% | Oct 12, 2026 |
| Stifel Nicolaus | Bruce Chan | $209 | $135.18 | +45.3% | Oct 8, 2026 |
| Truist Financial | Analyst unavailable | $200 | $134.44 | +39.1% | Oct 7, 2026 |
| Evercore ISI | Analyst unavailable | $217 | $134.92 | +50.9% | Oct 6, 2026 |
| Wells Fargo | Analyst unavailable | $203 | $140.61 | +41.1% | Oct 6, 2026 |
| Jefferies | Stephanie Moore | $220 | $140.61 | +53.0% | Oct 6, 2026 |
| Bernstein | David Vernon | $151 | $148.29 | +5.0% | Aug 11, 2026 |
| Stifel Nicolaus | Bruce Chan | $225 | $146.92 | +56.4% | Jul 31, 2026 |
| Evercore ISI | Jonathan Chappell | $237 | $149.13 | +64.8% | Jul 30, 2026 |
| Wolfe Research | Analyst unavailable | $196 | $150.9 | +36.3% | Jul 30, 2026 |
| Raymond James | Analyst unavailable | $192 | $173.75 | +33.5% | Jul 30, 2026 |
| Janney Montgomery | Analyst unavailable | $155 | $168.95 | +7.8% | Jul 28, 2026 |
| Robert W. Baird | Daniel Moore | $200 | $174.46 | +39.1% | Jul 28, 2026 |
| Deutsche Bank | Analyst unavailable | $220 | $209.42 | +53.0% | Jul 22, 2026 |
| Stifel Nicolaus | Bruce Chan | $215 | $199.61 | +49.5% | Jul 15, 2026 |
| Susquehanna | Analyst unavailable | $226 | $198.24 | +57.1% | Jul 14, 2026 |
| BMO Capital | Analyst unavailable | $190 | $196.5 | +32.1% | Jul 13, 2026 |
| Morgan Stanley | Analyst unavailable | $91 | $190.5 | -36.7% | Jul 6, 2026 |
| Raymond James | Analyst unavailable | $203 | $191.27 | +41.1% | Jul 2, 2026 |
| UBS | Analyst unavailable | $230 | $179.78 | +59.9% | Jun 1, 2026 |
| Jefferies | Stephanie Moore | $200 | $173.02 | +39.1% | May 20, 2026 |
| Robert W. Baird | Analyst unavailable | $230 | $179.87 | +59.9% | May 1, 2026 |
| Raymond James | Analyst unavailable | $210 | $187.2 | +46.0% | Apr 30, 2026 |
| Barclays | Analyst unavailable | $210 | $186.43 | +46.0% | Apr 30, 2026 |
| Evercore ISI | Jonathan Chappell | $205 | $167.66 | +42.5% | Mar 26, 2026 |
| Loop Capital Markets | Sergey Glinyanov | $206 | $197.26 | +43.2% | Feb 2, 2026 |
| UBS | Analyst unavailable | $160 | $194.71 | +11.3% | Jan 29, 2026 |
| Morgan Stanley | Analyst unavailable | $90 | $187.29 | -37.4% | Jan 29, 2026 |
| Truist Financial | Analyst unavailable | $210 | $188.74 | +46.0% | Jan 29, 2026 |
| Deutsche Bank | Analyst unavailable | $200 | $187.62 | +39.1% | Jan 29, 2026 |
| Stifel Nicolaus | Analyst unavailable | $202 | $190.76 | +40.5% | Jan 29, 2026 |
| Evercore ISI | Jonathan Chappell | $219 | $191.52 | +52.3% | Jan 29, 2026 |
| Robert W. Baird | Analyst unavailable | $203 | $184.28 | +41.1% | Jan 29, 2026 |
| Susquehanna | Analyst unavailable | $220 | $184.28 | +53.0% | Jan 29, 2026 |
| BMO Capital | Analyst unavailable | $180 | $192.53 | +25.2% | Jan 29, 2026 |
| Raymond James | Patrick Brown | $215 | $190.91 | +49.5% | Jan 29, 2026 |
| UBS | Thomas Wadewitz | $224 | $177.9 | +55.8% | Jan 23, 2026 |
| Truist Financial | Analyst unavailable | $190 | $174.54 | +32.1% | Jan 15, 2026 |
| Goldman Sachs | Analyst unavailable | $149 | $173.42 | +3.6% | Jan 14, 2026 |
| Evercore ISI | Analyst unavailable | $196 | $172.54 | +36.3% | Jan 12, 2026 |
| Bernstein | Analyst unavailable | $153 | $166.01 | +6.4% | Jan 9, 2026 |
| Wolfe Research | Analyst unavailable | $188 | $166.01 | +30.7% | Jan 8, 2026 |
| Susquehanna | Bascome Majors | $210 | $166.76 | +46.0% | Jan 8, 2026 |
| Robert W. Baird | Analyst unavailable | $175 | $164.64 | +21.7% | Jan 7, 2026 |
| Wells Fargo | Christian Wetherbee | $185 | $167.21 | +28.6% | Jan 6, 2026 |
| Stifel Nicolaus | Bruce Chan | $184 | $157.62 | +27.9% | Dec 16, 2025 |
| Barclays | Analyst unavailable | $200 | $157.62 | +39.1% | Dec 16, 2025 |
| Morgan Stanley | Analyst unavailable | $85 | $157.22 | -40.9% | Dec 8, 2025 |
| Barclays | Analyst unavailable | $145 | $154.88 | +0.8% | Oct 31, 2025 |
| Truist Financial | Analyst unavailable | $165 | $154.75 | +14.7% | Oct 30, 2025 |
| Bernstein | David Vernon | $135 | $155.56 | -6.1% | Oct 30, 2025 |
| Goldman Sachs | Analyst unavailable | $131 | $154.95 | -8.9% | Oct 30, 2025 |
| Stephens | Reed Seay | $173 | $129.38 | +20.3% | Oct 30, 2025 |
| UBS | Thomas Wadewitz | $177 | $129.38 | +23.1% | Oct 30, 2025 |
| Raymond James | Patrick Brown | $161 | $129.38 | +11.9% | Oct 30, 2025 |
| BMO Capital | Fadi Chamoun | $140 | $129.38 | -2.7% | Oct 30, 2025 |
| Truist Financial | Analyst unavailable | $150 | $125.57 | +4.3% | Oct 14, 2025 |
| Raymond James | Analyst unavailable | $158 | $124.39 | +9.9% | Oct 14, 2025 |
| Stifel Nicolaus | Analyst unavailable | $144 | $128.9 | +0.1% | Oct 10, 2025 |
| UBS | Analyst unavailable | $166 | $135 | +15.4% | Oct 3, 2025 |
| Barclays | Analyst unavailable | $130 | $132.66 | -9.6% | Oct 2, 2025 |
| Deutsche Bank | Richa Harnain | $159 | $132.66 | +10.6% | Oct 1, 2025 |
| Evercore ISI | Analyst unavailable | $155 | $131.87 | +7.8% | Sep 30, 2025 |
| Susquehanna | Bascome Majors | $160 | $133.3 | +11.3% | Sep 24, 2025 |
| Susquehanna | Bascome Majors | $165 | $132.44 | +14.7% | Sep 24, 2025 |
| UBS | Analyst unavailable | $133 | $97.65 | -7.5% | Jul 31, 2025 |
| Barclays | Brandon Oglenski | $95 | $97.65 | -33.9% | Jul 31, 2025 |
| Raymond James | David Hicks | $111 | $97.06 | -22.8% | Jul 15, 2025 |
| Susquehanna | Bascome Majors | $117 | $101.66 | -18.6% | Mar 26, 2025 |
| Deutsche Bank | Analyst unavailable | $129 | $102.45 | -10.3% | Mar 7, 2025 |
| Raymond James | David Hicks | $123 | $101.76 | -14.5% | Jan 10, 2025 |
| Susquehanna | Bascome Majors | $130 | $104.05 | -9.6% | Jan 3, 2025 |
| Wells Fargo | Christian Wetherbee | $130 | $108.14 | -9.6% | Dec 9, 2024 |
| BMO Capital | Fadi Chamoun | $115 | $109.64 | -20.0% | Oct 31, 2024 |
| UBS | Thomas Wadewitz | $140 | $105.5 | -2.7% | Oct 4, 2024 |
| Robert W. Baird | Benjamin Hartford | $115 | $110.04 | -20.0% | Oct 1, 2024 |
| Susquehanna | Bascome Majors | $120 | $108.02 | -16.6% | Sep 26, 2024 |
| Barclays | Brandon Oglenski | $75 | $102.21 | -47.9% | Aug 2, 2024 |
| Robert W. Baird | Garrett Holland | $100 | $89.05 | -30.5% | Aug 1, 2024 |
| Bank of America Securities | Ken Hoexter | $99 | $90.19 | -31.2% | Jul 22, 2024 |
| J.P. Morgan | Brian Ossenbeck | $87 | $87.6 | -39.5% | Jul 9, 2024 |
| Evercore ISI | Jonathan Chappell | $99 | $88.49 | -31.2% | Jun 25, 2024 |
| UBS | Thomas Wadewitz | $90 | $87.64 | -37.4% | Jun 6, 2024 |
| Stifel Nicolaus | Bruce Chan | $80 | $82.66 | -44.4% | May 21, 2024 |
| BMO Capital | Fadi Chamoun | $85 | $80.93 | -40.9% | May 3, 2024 |
| HSBC | Alexandre Falcao | $138 | $75.31 | -4.0% | Mar 14, 2024 |
| CFRA | Stewart Glickman | $95 | $81.43 | -33.9% | Nov 2, 2023 |
| Susquehanna | Analyst unavailable | $86 | $104.28 | -40.2% | Feb 2, 2023 |
| J.P. Morgan | Analyst unavailable | $87 | $103.96 | -39.5% | Feb 2, 2023 |
| BMO Capital | Analyst unavailable | $85 | $101.98 | -40.9% | Feb 2, 2023 |
| Morgan Stanley | Analyst unavailable | $64 | $102.12 | -55.5% | Feb 2, 2023 |
| Wells Fargo | Analyst unavailable | $95 | $102.12 | -33.9% | Feb 2, 2023 |
| Bernstein | Analyst unavailable | $92 | $102.12 | -36.0% | Feb 2, 2023 |
| J.P. Morgan | Analyst unavailable | $90 | $92.8 | -37.4% | Jan 11, 2023 |
| Goldman Sachs | Analyst unavailable | $93 | $93.36 | -35.3% | Jan 10, 2023 |
| BMO Capital | Analyst unavailable | $90 | $93.31 | -37.4% | Jan 9, 2023 |
| Credit Suisse | Analyst unavailable | $93 | $90.28 | -35.3% | Jan 4, 2023 |
| UBS | Analyst unavailable | $81 | $90.28 | -43.7% | Jan 4, 2023 |
| BNP Paribas | Robert Joynson | $128 | $97.41 | -11.0% | Nov 30, 2022 |
| Morgan Stanley | Analyst unavailable | $67 | $98.02 | -53.4% | Oct 3, 2022 |
| Morgan Stanley | Analyst unavailable | $66 | $107.99 | -54.1% | Jul 28, 2022 |
| Wells Fargo | Analyst unavailable | $94 | $101.13 | -34.6% | Jul 28, 2022 |
| Wells Fargo | Analyst unavailable | $93 | $95.57 | -35.3% | Jul 15, 2022 |
| J.P. Morgan | Analyst unavailable | $120 | $109.56 | -16.6% | Apr 28, 2022 |
| Citigroup | Analyst unavailable | $120 | $108.92 | -16.6% | Apr 28, 2022 |
| Susquehanna | Analyst unavailable | $107 | $108.9 | -25.6% | Apr 28, 2022 |
| Robert W. Baird | Analyst unavailable | $115 | $107.94 | -20.0% | Apr 28, 2022 |
| BMO Capital | Analyst unavailable | $110 | $102.83 | -23.5% | Apr 28, 2022 |
| Barclays | Brandon Oglenski | $100 | $89.08 | -30.5% | Feb 3, 2022 |
| Citigroup | Christian Wetherbee | $180 | $89.08 | +25.2% | Feb 3, 2022 |
| Morgan Stanley | Ravi Shanker | $62 | $89.08 | -56.9% | Feb 3, 2022 |
| KeyBanc | Todd Fowler | $125 | $89.08 | -13.1% | Feb 3, 2022 |
| UBS | Thomas Wadewitz | $94 | $89.08 | -34.6% | Feb 3, 2022 |
| BMO Capital | Fadi Chamoun | $105 | $89.08 | -27.0% | Feb 3, 2022 |
| Benchmark Co. | Christopher Kuhn | $125 | $102.27 | -13.1% | Jan 27, 2022 |
| Evercore ISI | Jonathan Chappell | $117 | $107.4 | -18.6% | Jan 11, 2022 |
| Susquehanna | Bascome Majors | $93 | $87.07 | -35.3% | Jul 28, 2021 |
| Goldman Sachs | Jordan Alliger | $108 | $96.95 | -24.9% | Jun 7, 2021 |
Track every rating change on CHRW the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationC.H. Robinson Worldwide, Inc. serves as a global provider of diverse freight transportation and logistics solutions, assisting companies across numerous industries. The organization's business operations are segmented into two key areas: North American Surface Transportation and Global Forwarding. Its comprehensive range of services spans various shipping modalities. This includes brokerage for both full truckload (FTL) and less-than-truckload (LTL) freight, managing everything from single-pallet shipments to full container loads. C.H. Robinson also coordinates intermodal transport, which involves moving goods in containers or trailers through a combination of truck and rail networks, in addition to acting as a non-vessel operating common carrier (NVOCC) for ocean freight and arranging air cargo shipments. The company consistently provides end-to-end door-to-door delivery services.…
Historical context
All CHRW earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FAST Fastenal Company | FY2026 Q3 · Calendar Q4 2026 | +3.3% | +1.1% | Fastenal Q3: Share Gains and Digital Adoption Lift Growth |
Latest beats and misses
Who reports nextBeat on EPS
Get the CHRW recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-16T08:50:44.207573+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-16T08:50:44.203947+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-16. For educational purposes only; not investment advice.